San Francisco, CA - Lee et al published (Antibody Targeting of Stem Cells to Infarcted Myocardium. Stem Cells. 2006 Nov 30; [Epub ahead of print]) a novel technique of increasing the concentration of stem cells to specific injured tissue. The investigators generated an antibody-like molecule of which one end binds to stem cells (well the actual antibody, anti-CD45) binds to many...
Frankfurt, Germany The concept of utilizing bone marrow cells to decrease scar tissue and improve patient prognosis after myocardial infarction has been previously tested clinically in patients. The majority of previous trials involved administration of autologous bone marrow within a certain time frame (usually 2-12 days) after the myocardial infarct. The reason for this is that...